Browse Calcium channel blockers topic

Subtopics (7) Adverse and side effects Complications and side effects Dosage and administration Evaluation Health aspects Physiological aspects Research

Articles 1-25 out of 25 article(s) Title Author Type Date Words Integrating B vitamins with calcium channel blockers. Scozzari, James S. Jul 1, 2007 1108 The revised guidelines for the treatment of pulmonary arterial hypertension caution against the use of calcium channel blockers--used to combat high blood pressure--in unstable patients. Brief Article Oct 1, 2005 64 Calcium channel blockers controversy: a review of the literature. Benghuzzi, Hamed A. Jul 1, 2004 5627 Amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients. Kuritzky, Louis Brief Article Mar 1, 2003 185 Biovail's Tiazac Approved for Angina. Feb 3, 1998 274 Biovail Corporation and Novopharm Limited Sign Exclusive Agreement to Market Generic Version of Cardizem CD in Canada. Oct 1, 1997 528 Biovail Names Scandinavian Licensee for Tiazac. Sep 16, 1997 280 Pall is finally lifting from calcium channel blockers. Sep 1, 1997 187 Biovail Files Verelan Generic ANDA; Represents second ANDA filing for Biovail in 1997. Apr 30, 1997 309 Biovail reports first quarter 1997 financial results; confirms ANDA filing for generic Cardizem CD in the U.S.; Signs new European Licensing Agreements for Tiazac. Apr 28, 1997 1113 ITALY - CALCIUM CHANNEL BLOCKERS REDUCE STROKES. Jan 1, 1997 156 Biovail announces the signing of European licensing agreements governing three markets for its once daily Diltiazem product. Nov 5, 1996 542 Teva Pharmaceutical Industries, Ltd. announces FDA approval of Nicardipine. Oct 29, 1996 131 Hypertension drug linked to cancer? Brief Article Sep 14, 1996 295 Mylan receives first approval on Nicardipine. Jul 19, 1996 77 Neurex' SNX-111 in the Treatment of Neuropathic Pain Caused by AIDS; Early Results Promising. Mar 11, 1996 374 Zeneca Launching New Calcium Channel Blocker. Jan 4, 1996 373 Controversial warning for heart drug. Travis, John Sep 9, 1995 571 ZENECA PHARMACEUETICALS AND BAYER SIGN A LETTER OF INTENT FOR ZENECA TO MARKET CALCIUM CHANNEL BLOCKER, SULAR (NISOLDIPINE) IN THE US. Aug 3, 1995 212 a blood-pressure drug that may cause heart attacks? Brown, Edwin W. Jul 1, 1995 530 SIBIA and Eli Lilly extend research agreement for discovery of calcium channel drugs. Jun 13, 1995 427 Drug fails to arrest cardiac aftereffects. Fackelmann, Kathy A. May 4, 1991 593 Mystery mechanism keeps nerve cells alive. Cowen, Ron Jun 16, 1990 479 Channeling new drugs to ischemic hearts. Cowen, R. Mar 17, 1990 635 Doubts about another heart drug. Dec 1, 1989 385